Italia markets closed

Xvivo Perfusion AB (publ) (0RKL.L)

LSE - LSE Prezzo differito. Valuta in SEK.
Aggiungi a watchlist
275,000,00 (0,00%)
Alla chiusura: 05:59PM GMT

Xvivo Perfusion AB (publ)

MAessans gata 10
Gothenburg 412 51
Sweden
46 3 17 88 21 50
https://www.xvivoperfusion.com

Settore/i
Settore
Impiegati a tempo pieno150

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Christoffer RosenbladChief Executive OfficerN/DN/D1975
Mr. Kristoffer NordstromCFO & Investor RelationsN/DN/D1985
Ms. Lena Hagman B.Sc.Chief Operating OfficerN/DN/D1965
Ms. Ylva VihojGlobal Human Resources DirectorN/DN/D1970
Dr. Magnus Nilsson Ph.D.Senior AdvisorN/DN/D1956
Mr. Andreas Wallinder M.D., Ph.D.Chief Medical OfficerN/DN/D1977
Mr. Johan HolmstromChief Commercial OfficerN/DN/D1970
Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Xvivo Perfusion AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.